Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label updated from v3.6.4 to v3.6.5, signaling a new edition of the page. This indicates minor updates or corrections have been made since the last revision.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision label was updated to v3.6.4, replacing the previous revision tag to reflect a minor metadata update.SummaryDifference0.0%

- Check49 days agoChange DetectedA new revision tag Revision: v3.6.3 was added to the page. The previous Revision: v3.6.2 was removed, reflecting a minor version update.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page’s revision tag was updated from Revision: v3.6.0 to Revision: v3.6.2, representing a small version update in the page metadata.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now indicates that no participants are being recruited and adds user-focused guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Interventions header formatting and the site revision label (from v3.5.5 to v3.6.0).SummaryDifference0.3%

- Check78 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This indicates a minor update to the page's content or metadata.SummaryDifference0.0%

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.